On 25 September, world leaders will gather at the United Nations for the Fourth High-Level Meeting on Noncommunicable Diseases (NCDs). It comes at a pivotal moment: funding for global health has plummeted, while NCDs like heart disease, cancer and diabetes continue to claim 75% of all lives lost worldwide. This amid recent efforts to water […] Continue reading ->
In a 4 September message,  the WHO/HQ Staff Association called for an Extraordinary General Assembly (EGA), now due to take place on Monday, 22 September. The message acknowledged what many staff were feeling: profound change, deep uncertainty, and a heavy personal and professional toll. Their statement flagged key concerns raised by many WHO staff about […] Continue reading ->
WHO’s 2025 Essential Medicines Lists (EML), published Friday, has included the active ingredients in popular weight loss drugs like Ozempic and Wegovy –  semaglutide or other comparable  GLP-1 receptor agonists – in a recommendation that recognizes the growing importance of the drugs in clinical treatment of diabetes worldwide.  These drugs, as well as new PD-1/PD-L1 […] Continue reading ->
There is mounting rage amongst World Health Organization’s (WHO) staff about planned workforce reductions, as new financial data suggests that low- and mid-level personnel are bearing the brunt of cuts—while high-ranking executives, whose real costs far exceed their published salaries, remain largely protected. In an email to WHO staff last week, WHO Director General Dr […] Continue reading ->